{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:PARP",
      "entity_text" : "PARP",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06078",
      "entity_text" : "HDACs",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Inhibitors of PARP enzymes and histone deacetylases (HDACs) have entered clinical trials or clinical use in cancer treatment 19, 82.",
  "reading_complete" : "2020-08-08T15:32:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:30:05Z",
  "trigger" : "Inhibitors",
  "evidence" : [ "Inhibitors of PARP enzymes and histone deacetylases (HDACs" ],
  "pmc_id" : "5333460",
  "score" : 0
}